Completed PHASE4 INTERVENTIONAL 2-arm NCT03376464

Xeomin Cosmetic in the Management of Masseter

Prospective Evaluation of Xeomin Cosmetic in the Management of the Masseter Using Two Different Injection Techniques

Sponsor: Erevna Innovations Inc.

Updated 5 times since 2018 Last updated: Dec 13, 2017 Started: Nov 6, 2015 Primary completion: Jan 31, 2017 Completion: Oct 11, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Masseter Muscle Hypertrophy and is currently completed. Erevna Innovations Inc. leads this study, which shows 5 recorded versions since 2015 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2018 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Nov 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Erevna Innovations Inc.

Data source: Erevna Innovations Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.